MESO
vs
U
USBC
MESO
Over the past 12 months, MESO has underperformed USBC, delivering a return of -7% compared to the USBC's +549 600% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
MESO
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Mesoblast Ltd
NASDAQ:MESO
|
18.7
USD
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.5497
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
MESO, USBC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Mesoblast Ltd
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
MESO, USBC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Mesoblast Ltd
NASDAQ:MESO
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
MESO, USBC
Performance Gap
MESO, USBC
Performance By Year
MESO, USBC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
